The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $823,473 Cooperative Agreement under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to The General Hospital Corporation (Massachusetts General Hospital) to conduct a 5-year research project titled "Longitudinal Omics-Based Trajectories of Type 2 Diabetes Subtypes: The T2D Heterogeneity Consortium". The goal is to use multi-omic data to refine definitions of prediabetes and type 2 diabetes, identify disease subtypes, and describe associations with complications and environmental factors to develop better diagnostic tools. The project will leverage data from multiple cohorts, including MESA, ARIC, HCHS/SOL, and the All of Us program, with specialized expertise provided by sub-awardees such as Beth Israel Deaconess Medical Center, Cedars-Sinai Medical Center, Lundquist Institute, Johns Hopkins University, and Baylor College of Medicine.
Generated 3/4/25, 4:32 AM